TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 187 filers reported holding TG THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,081 | +1045.2% | 165,414 | +672.4% | 0.66% | +804.1% |
| Q1 2023 | $531 | -90.3% | 21,415 | -20.3% | 0.07% | -91.2% |
| Q4 2022 | $5,498 | -99.9% | 26,856 | -98.2% | 0.83% | -48.6% |
| Q3 2022 | $10,696,000 | +677.9% | 1,469,283 | +3015.0% | 1.62% | +562.0% |
| Q2 2022 | $1,375,000 | -70.7% | 47,168 | -5.5% | 0.24% | -68.1% |
| Q1 2022 | $4,690,000 | -3.3% | 49,926 | +1318.4% | 0.77% | -7.0% |
| Q4 2021 | $4,848,000 | -5.9% | 3,520 | -91.3% | 0.83% | +32.5% |
| Q3 2021 | $5,151,000 | +172.7% | 40,321 | +49.8% | 0.62% | +184.9% |
| Q2 2021 | $1,889,000 | +22.6% | 26,923 | -15.8% | 0.22% | -19.5% |
| Q1 2021 | $1,541,000 | -5.9% | 31,975 | +1.6% | 0.27% | +37.4% |
| Q4 2020 | $1,637,000 | – | 31,473 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
| Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
| Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
| BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
| Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
| 683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
| Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
| Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |